Last week, another Novo executive indicated that Ozempic would "very likely" be included in the 2027 list. read more
‘Miracle’ Weight Loss Drug Ozempic To Enter US Price Negotiations Within A Year, Novo Nordisk CEO Says Ahead Of Senate Hearing
Read Also
- ASEAN ‘best economic opportunity’ over medium term, European businesses say
- Reviving India’s sugar industry: Unlocking the potential of stored syrup technology
- Partnership taxes: A guide for beginners
- Las Vegas Strip casino signs rock superstar for new residency
- Latest federal pitch might steer Chinese cars off US roads
- How To Earn $500 A Month From NVIDIA Stock
- New flights to 6 cities from Hyderabad airport
- Evaluating Crescent Energy: Insights From 7 Financial Analysts
- A Closer Look at 15 Analyst Recommendations For Sunrun
- Expert Ratings For TransMedics Gr
Latest Benzinga
- How To Earn $500 A Month From NVIDIA Stock
- Evaluating Crescent Energy: Insights From 7 Financial Analysts
- A Closer Look at 15 Analyst Recommendations For Sunrun
- Expert Ratings For TransMedics Gr
- Cracking The Code: Understanding Analyst Reviews For First Citizens BancShares
- Analyst Ratings For Taboola.com
- EXCLUSIVE: Guardforce H1'24 Earnings: 50% Jump in Gross Profit, Turns Net Income Positive, Expands AI Solutions
- A Potential Calm Before The Storm Could Draw Intrigue In Direxion's NVDU And NVDD Funds
- Critical Insights From Salesforce Analyst Ratings: What You Need To Know
- Generations Bancorp's $26.2M Sale To ESL Federal: Big Payouts Await Shareholders As Bank Prepares For Liquidation